nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CYP1B1—Dexamethasone—atopic dermatitis	0.0734	0.133	CbGbCtD
Arsenic trioxide—CYP3A4—Pimecrolimus—atopic dermatitis	0.05	0.0904	CbGbCtD
Arsenic trioxide—ABCB1—Tacrolimus—atopic dermatitis	0.0497	0.0898	CbGbCtD
Arsenic trioxide—ABCC2—Dexamethasone—atopic dermatitis	0.0386	0.0697	CbGbCtD
Arsenic trioxide—ABCB1—Loratadine—atopic dermatitis	0.0364	0.0657	CbGbCtD
Arsenic trioxide—ABCB1—Methylprednisolone—atopic dermatitis	0.0333	0.0601	CbGbCtD
Arsenic trioxide—CYP1A1—Dexamethasone—atopic dermatitis	0.0322	0.0582	CbGbCtD
Arsenic trioxide—CYP3A4—Tacrolimus—atopic dermatitis	0.0298	0.0538	CbGbCtD
Arsenic trioxide—CYP3A4—Loratadine—atopic dermatitis	0.0218	0.0394	CbGbCtD
Arsenic trioxide—ABCB1—Betamethasone—atopic dermatitis	0.0216	0.0391	CbGbCtD
Arsenic trioxide—ABCB1—Prednisolone—atopic dermatitis	0.0213	0.0386	CbGbCtD
Arsenic trioxide—ABCB1—Hydrocortisone—atopic dermatitis	0.0202	0.0365	CbGbCtD
Arsenic trioxide—ABCB1—Prednisone—atopic dermatitis	0.0201	0.0364	CbGbCtD
Arsenic trioxide—CYP3A4—Methylprednisolone—atopic dermatitis	0.0199	0.036	CbGbCtD
Arsenic trioxide—CCND1—skin epidermis—atopic dermatitis	0.0156	0.142	CbGeAlD
Arsenic trioxide—CYP3A4—Triamcinolone—atopic dermatitis	0.0151	0.0273	CbGbCtD
Arsenic trioxide—CYP3A4—Betamethasone—atopic dermatitis	0.013	0.0234	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisolone—atopic dermatitis	0.0128	0.0231	CbGbCtD
Arsenic trioxide—ABCB1—Dexamethasone—atopic dermatitis	0.0126	0.0227	CbGbCtD
Arsenic trioxide—CYP3A4—Hydrocortisone—atopic dermatitis	0.0121	0.0219	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisone—atopic dermatitis	0.0121	0.0218	CbGbCtD
Arsenic trioxide—AKT1—skin epidermis—atopic dermatitis	0.011	0.1	CbGeAlD
Arsenic trioxide—JUN—skin epidermis—atopic dermatitis	0.00957	0.087	CbGeAlD
Arsenic trioxide—CYP3A4—Dexamethasone—atopic dermatitis	0.00754	0.0136	CbGbCtD
Arsenic trioxide—CCND1—neck—atopic dermatitis	0.00748	0.0681	CbGeAlD
Arsenic trioxide—MAPK3—neck—atopic dermatitis	0.00558	0.0508	CbGeAlD
Arsenic trioxide—AKT1—neck—atopic dermatitis	0.00526	0.0479	CbGeAlD
Arsenic trioxide—CCND1—skin of body—atopic dermatitis	0.00484	0.0441	CbGeAlD
Arsenic trioxide—JUN—neck—atopic dermatitis	0.00458	0.0417	CbGeAlD
Arsenic trioxide—MAPK1—skin of body—atopic dermatitis	0.00408	0.0371	CbGeAlD
Arsenic trioxide—TXNRD1—skin of body—atopic dermatitis	0.0038	0.0346	CbGeAlD
Arsenic trioxide—MAPK3—skin of body—atopic dermatitis	0.00361	0.0329	CbGeAlD
Arsenic trioxide—CYP1A1—skin epidermis—atopic dermatitis	0.00361	0.0328	CbGeAlD
Arsenic trioxide—AKT1—skin of body—atopic dermatitis	0.00341	0.031	CbGeAlD
Arsenic trioxide—CCND1—head—atopic dermatitis	0.00316	0.0287	CbGeAlD
Arsenic trioxide—JUN—skin of body—atopic dermatitis	0.00296	0.027	CbGeAlD
Arsenic trioxide—IKBKB—skin of body—atopic dermatitis	0.00295	0.0268	CbGeAlD
Arsenic trioxide—MAPK1—head—atopic dermatitis	0.00266	0.0242	CbGeAlD
Arsenic trioxide—TXNRD1—head—atopic dermatitis	0.00248	0.0225	CbGeAlD
Arsenic trioxide—MAPK3—head—atopic dermatitis	0.00236	0.0214	CbGeAlD
Arsenic trioxide—AKT1—head—atopic dermatitis	0.00222	0.0202	CbGeAlD
Arsenic trioxide—JUN—head—atopic dermatitis	0.00193	0.0176	CbGeAlD
Arsenic trioxide—IKBKB—head—atopic dermatitis	0.00192	0.0175	CbGeAlD
Arsenic trioxide—CYP1B1—skin of body—atopic dermatitis	0.00158	0.0144	CbGeAlD
Arsenic trioxide—CYP1A1—skin of body—atopic dermatitis	0.00112	0.0102	CbGeAlD
Arsenic trioxide—CYP1B1—head—atopic dermatitis	0.00103	0.00938	CbGeAlD
Arsenic trioxide—AKT1—Temsirolimus—Tacrolimus—atopic dermatitis	0.000781	0.0824	CbGdCrCtD
Arsenic trioxide—AKT1—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000781	0.0824	CbGdCrCtD
Arsenic trioxide—CYP1A1—head—atopic dermatitis	0.000729	0.00663	CbGeAlD
Arsenic trioxide—ABCB1—head—atopic dermatitis	0.000379	0.00344	CbGeAlD
Arsenic trioxide—TXNRD1—Flunisolide—Desonide—atopic dermatitis	0.000302	0.0318	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Desonide—atopic dermatitis	0.000298	0.0314	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Desonide—atopic dermatitis	0.000298	0.0314	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Fluocinonide—atopic dermatitis	0.000242	0.0255	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Fluocinonide—atopic dermatitis	0.000239	0.0252	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Fluocinonide—atopic dermatitis	0.000239	0.0252	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Fluocinolone Acetonide—atopic dermatitis	0.000235	0.0248	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000233	0.0246	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000232	0.0245	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000232	0.0245	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000227	0.0239	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Mometasone—atopic dermatitis	0.000187	0.0198	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Mometasone—atopic dermatitis	0.000185	0.0195	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Mometasone—atopic dermatitis	0.000185	0.0195	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000181	0.0191	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Desonide—atopic dermatitis	0.000148	0.0156	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Desonide—atopic dermatitis	0.000148	0.0156	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Hydrocortisone—atopic dermatitis	0.000119	0.0125	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Fluocinonide—atopic dermatitis	0.000118	0.0125	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Fluocinonide—atopic dermatitis	0.000118	0.0125	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000117	0.0124	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Hydrocortisone—atopic dermatitis	0.000117	0.0124	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000115	0.0121	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000115	0.0121	CbGdCrCtD
Arsenic trioxide—TXNRD1—Testosterone—Hydrocortisone—atopic dermatitis	0.000112	0.0118	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Methylprednisolone—atopic dermatitis	0.000112	0.0118	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Methylprednisolone—atopic dermatitis	0.00011	0.0117	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Methylprednisolone—atopic dermatitis	0.00011	0.0117	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Betamethasone—atopic dermatitis	0.00011	0.0116	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Dexamethasone—atopic dermatitis	0.00011	0.0116	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Dexamethasone—atopic dermatitis	0.000109	0.0115	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Betamethasone—atopic dermatitis	0.000109	0.0115	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000108	0.0114	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Triamcinolone—atopic dermatitis	0.000108	0.0114	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000106	0.0112	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000106	0.0112	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Triamcinolone—atopic dermatitis	0.000106	0.0112	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Triamcinolone—atopic dermatitis	0.000106	0.0112	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.000104	0.011	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisone—atopic dermatitis	0.000102	0.0108	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisone—atopic dermatitis	0.000101	0.0106	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisone—atopic dermatitis	0.000101	0.0106	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisolone—atopic dermatitis	9.97e-05	0.0105	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisolone—atopic dermatitis	9.84e-05	0.0104	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisolone—atopic dermatitis	9.84e-05	0.0104	CbGdCrCtD
Arsenic trioxide—TXNRD1—Testosterone—Prednisolone—atopic dermatitis	9.41e-05	0.00993	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Mometasone—atopic dermatitis	9.17e-05	0.00968	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Mometasone—atopic dermatitis	9.17e-05	0.00968	CbGdCrCtD
Arsenic trioxide—TXNRD1—Norethindrone—Hydrocortisone—atopic dermatitis	8.19e-05	0.00865	CbGdCrCtD
Arsenic trioxide—TXNRD1—Levonorgestrel—Hydrocortisone—atopic dermatitis	6.52e-05	0.00688	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Hydrocortisone—atopic dermatitis	5.8e-05	0.00612	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Hydrocortisone—atopic dermatitis	5.8e-05	0.00612	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Methylprednisolone—atopic dermatitis	5.48e-05	0.00578	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Methylprednisolone—atopic dermatitis	5.48e-05	0.00578	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Dexamethasone—atopic dermatitis	5.39e-05	0.00569	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Betamethasone—atopic dermatitis	5.39e-05	0.00569	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Triamcinolone—atopic dermatitis	5.27e-05	0.00556	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Triamcinolone—atopic dermatitis	5.27e-05	0.00556	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisone—atopic dermatitis	5e-05	0.00527	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisone—atopic dermatitis	5e-05	0.00527	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisolone—atopic dermatitis	4.88e-05	0.00515	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisolone—atopic dermatitis	4.88e-05	0.00515	CbGdCrCtD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	3.11e-05	9.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—IL6—atopic dermatitis	3.11e-05	9.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—IL6—atopic dermatitis	3.11e-05	9.49e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.1e-05	9.49e-05	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.09e-05	9.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—IL6—atopic dermatitis	3.08e-05	9.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CXCL10—atopic dermatitis	3.07e-05	9.38e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CASP8—atopic dermatitis	3.07e-05	9.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—STAT6—atopic dermatitis	3.05e-05	9.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—IL6—atopic dermatitis	3.05e-05	9.33e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD79A—atopic dermatitis	3.04e-05	9.3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—IL6—atopic dermatitis	3.04e-05	9.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—NFKBIA—atopic dermatitis	3.01e-05	9.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CCL5—atopic dermatitis	3e-05	9.17e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3e-05	9.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL11—atopic dermatitis	3e-05	9.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CMA1—atopic dermatitis	3e-05	9.16e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL5—atopic dermatitis	3e-05	9.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—TLR2—atopic dermatitis	2.99e-05	9.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—IL6—atopic dermatitis	2.99e-05	9.13e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	2.98e-05	9.11e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	2.97e-05	9.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—STAT6—atopic dermatitis	2.96e-05	9.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD79A—atopic dermatitis	2.95e-05	9.02e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CASP8—atopic dermatitis	2.95e-05	9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCL10—atopic dermatitis	2.92e-05	8.93e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.92e-05	8.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	2.89e-05	8.84e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—NFKBIA—atopic dermatitis	2.88e-05	8.81e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL11—atopic dermatitis	2.87e-05	8.76e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CMA1—atopic dermatitis	2.87e-05	8.76e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—TLR2—atopic dermatitis	2.86e-05	8.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CASP8—atopic dermatitis	2.86e-05	8.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—STAT6—atopic dermatitis	2.82e-05	8.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD79A—atopic dermatitis	2.81e-05	8.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.79e-05	8.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—NFKBIA—atopic dermatitis	2.77e-05	8.46e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCR3—atopic dermatitis	2.76e-05	8.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	2.75e-05	8.41e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CCL5—atopic dermatitis	2.73e-05	8.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CASP8—atopic dermatitis	2.72e-05	8.31e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CCR5—atopic dermatitis	2.7e-05	8.26e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—STAT6—atopic dermatitis	2.7e-05	8.24e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD79A—atopic dermatitis	2.69e-05	8.21e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—NFKBIA—atopic dermatitis	2.68e-05	8.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.66e-05	8.13e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCR3—atopic dermatitis	2.65e-05	8.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CCL5—atopic dermatitis	2.64e-05	8.08e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GLB1—atopic dermatitis	2.62e-05	8.02e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CASP8—atopic dermatitis	2.6e-05	7.95e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL18—atopic dermatitis	2.59e-05	7.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCR3—atopic dermatitis	2.57e-05	7.85e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD8A—atopic dermatitis	2.55e-05	7.8e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—IL6—atopic dermatitis	2.54e-05	7.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CD4—atopic dermatitis	2.52e-05	7.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CCL5—atopic dermatitis	2.52e-05	7.69e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ADSL—atopic dermatitis	2.51e-05	7.69e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL18—atopic dermatitis	2.49e-05	7.61e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—IL2—atopic dermatitis	2.47e-05	7.55e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NPS—atopic dermatitis	2.46e-05	7.5e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TAC1—atopic dermatitis	2.46e-05	7.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CCR5—atopic dermatitis	2.46e-05	7.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD8A—atopic dermatitis	2.45e-05	7.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCR3—atopic dermatitis	2.44e-05	7.47e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CD4—atopic dermatitis	2.42e-05	7.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL18—atopic dermatitis	2.42e-05	7.38e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCR3—atopic dermatitis	2.41e-05	7.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—IL2—atopic dermatitis	2.4e-05	7.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CCR5—atopic dermatitis	2.38e-05	7.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD8A—atopic dermatitis	2.38e-05	7.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—IL6—atopic dermatitis	2.37e-05	7.25e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NPS—atopic dermatitis	2.36e-05	7.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TAC1—atopic dermatitis	2.36e-05	7.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CD4—atopic dermatitis	2.35e-05	7.17e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCR3—atopic dermatitis	2.34e-05	7.14e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD4—atopic dermatitis	2.32e-05	7.1e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCR3—atopic dermatitis	2.31e-05	7.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL18—atopic dermatitis	2.3e-05	7.02e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—IL6—atopic dermatitis	2.29e-05	7.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NPS—atopic dermatitis	2.29e-05	6.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TAC1—atopic dermatitis	2.29e-05	6.99e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL5—atopic dermatitis	2.28e-05	6.98e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—IL2—atopic dermatitis	2.28e-05	6.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CCR5—atopic dermatitis	2.27e-05	6.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD8A—atopic dermatitis	2.26e-05	6.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IL6—atopic dermatitis	2.26e-05	6.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—IL6—atopic dermatitis	2.26e-05	6.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCR3—atopic dermatitis	2.24e-05	6.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CD4—atopic dermatitis	2.23e-05	6.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—IL6—atopic dermatitis	2.22e-05	6.8e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL18—atopic dermatitis	2.2e-05	6.72e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL5—atopic dermatitis	2.19e-05	6.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NPS—atopic dermatitis	2.18e-05	6.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TAC1—atopic dermatitis	2.18e-05	6.65e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD8A—atopic dermatitis	2.17e-05	6.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL6—atopic dermatitis	2.15e-05	6.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—PPARA—atopic dermatitis	2.14e-05	6.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CD4—atopic dermatitis	2.14e-05	6.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCR3—atopic dermatitis	2.14e-05	6.53e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—MAPK8—atopic dermatitis	2.13e-05	6.52e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL5—atopic dermatitis	2.13e-05	6.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—IL6—atopic dermatitis	2.12e-05	6.47e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GLB1—atopic dermatitis	2.1e-05	6.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NPS—atopic dermatitis	2.08e-05	6.37e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TAC1—atopic dermatitis	2.08e-05	6.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—PPARA—atopic dermatitis	2.07e-05	6.34e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CCR5—atopic dermatitis	2.07e-05	6.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL6—atopic dermatitis	2.06e-05	6.29e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD4—atopic dermatitis	2.05e-05	6.27e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—MAPK8—atopic dermatitis	2.05e-05	6.26e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCR3—atopic dermatitis	2.04e-05	6.24e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.03e-05	6.2e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—IL6—atopic dermatitis	2.02e-05	6.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL5—atopic dermatitis	2.02e-05	6.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—IL6—atopic dermatitis	2.01e-05	6.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CCR5—atopic dermatitis	2.01e-05	6.14e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ADSL—atopic dermatitis	2.01e-05	6.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—MAPK8—atopic dermatitis	1.99e-05	6.07e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—NFKBIA—atopic dermatitis	1.98e-05	6.05e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCL10—atopic dermatitis	1.95e-05	5.95e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL5—atopic dermatitis	1.94e-05	5.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—IL6—atopic dermatitis	1.92e-05	5.85e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.91e-05	5.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CCR5—atopic dermatitis	1.91e-05	5.84e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CXCL8—atopic dermatitis	1.91e-05	5.84e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—NFKBIA—atopic dermatitis	1.9e-05	5.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—MAPK8—atopic dermatitis	1.89e-05	5.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL10—atopic dermatitis	1.87e-05	5.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—NFKBIA—atopic dermatitis	1.84e-05	5.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—atopic dermatitis	1.84e-05	5.61e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL2—atopic dermatitis	1.83e-05	5.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL10—atopic dermatitis	1.81e-05	5.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—MAPK8—atopic dermatitis	1.81e-05	5.53e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CASP8—atopic dermatitis	1.79e-05	5.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—atopic dermatitis	1.78e-05	5.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—NFKBIA—atopic dermatitis	1.76e-05	5.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL10—atopic dermatitis	1.73e-05	5.27e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CASP8—atopic dermatitis	1.72e-05	5.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—atopic dermatitis	1.69e-05	5.18e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MAPK8—atopic dermatitis	1.68e-05	5.13e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—NFKBIA—atopic dermatitis	1.68e-05	5.13e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCL5—atopic dermatitis	1.68e-05	5.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CASP8—atopic dermatitis	1.66e-05	5.08e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PPARA—atopic dermatitis	1.66e-05	5.08e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL10—atopic dermatitis	1.65e-05	5.05e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.63e-05	5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL5—atopic dermatitis	1.61e-05	4.92e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.6e-05	4.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CASP8—atopic dermatitis	1.58e-05	4.84e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—IL2—atopic dermatitis	1.56e-05	4.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL5—atopic dermatitis	1.56e-05	4.77e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NGF—atopic dermatitis	1.55e-05	4.74e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IFNG—atopic dermatitis	1.52e-05	4.64e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CASP8—atopic dermatitis	1.51e-05	4.63e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCR5—atopic dermatitis	1.51e-05	4.61e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NGF—atopic dermatitis	1.49e-05	4.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL5—atopic dermatitis	1.49e-05	4.54e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CXCL8—atopic dermatitis	1.48e-05	4.54e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—IL6—atopic dermatitis	1.48e-05	4.53e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD4—atopic dermatitis	1.47e-05	4.48e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IFNG—atopic dermatitis	1.46e-05	4.46e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.45e-05	4.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCR5—atopic dermatitis	1.45e-05	4.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NGF—atopic dermatitis	1.45e-05	4.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CXCL8—atopic dermatitis	1.44e-05	4.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—IL6—atopic dermatitis	1.44e-05	4.39e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL5—atopic dermatitis	1.42e-05	4.34e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL2—atopic dermatitis	1.42e-05	4.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IFNG—atopic dermatitis	1.41e-05	4.32e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD4—atopic dermatitis	1.41e-05	4.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCR5—atopic dermatitis	1.41e-05	4.3e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PPARA—atopic dermatitis	1.38e-05	4.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NGF—atopic dermatitis	1.38e-05	4.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL2—atopic dermatitis	1.38e-05	4.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCL8—atopic dermatitis	1.37e-05	4.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—atopic dermatitis	1.37e-05	4.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD4—atopic dermatitis	1.37e-05	4.18e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—atopic dermatitis	1.36e-05	4.16e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—atopic dermatitis	1.35e-05	4.14e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL2—atopic dermatitis	1.35e-05	4.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IFNG—atopic dermatitis	1.35e-05	4.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCR5—atopic dermatitis	1.34e-05	4.09e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NGF—atopic dermatitis	1.32e-05	4.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL2—atopic dermatitis	1.31e-05	4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—atopic dermatitis	1.31e-05	4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—atopic dermatitis	1.3e-05	3.98e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD4—atopic dermatitis	1.3e-05	3.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD4—atopic dermatitis	1.3e-05	3.97e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL2—atopic dermatitis	1.3e-05	3.96e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.29e-05	3.94e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IFNG—atopic dermatitis	1.29e-05	3.94e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCR5—atopic dermatitis	1.28e-05	3.91e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NFKBIA—atopic dermatitis	1.28e-05	3.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—atopic dermatitis	1.27e-05	3.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—atopic dermatitis	1.26e-05	3.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD4—atopic dermatitis	1.26e-05	3.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL2—atopic dermatitis	1.26e-05	3.84e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD4—atopic dermatitis	1.24e-05	3.8e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MAPK8—atopic dermatitis	1.24e-05	3.79e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.24e-05	3.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NFKBIA—atopic dermatitis	1.23e-05	3.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—atopic dermatitis	1.21e-05	3.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—atopic dermatitis	1.2e-05	3.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD4—atopic dermatitis	1.2e-05	3.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL2—atopic dermatitis	1.2e-05	3.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MAPK8—atopic dermatitis	1.19e-05	3.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NFKBIA—atopic dermatitis	1.19e-05	3.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MAPK8—atopic dermatitis	1.16e-05	3.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—atopic dermatitis	1.15e-05	3.53e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—atopic dermatitis	1.15e-05	3.51e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL2—atopic dermatitis	1.14e-05	3.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.13e-05	3.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MAPK8—atopic dermatitis	1.1e-05	3.36e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NFKBIA—atopic dermatitis	1.09e-05	3.32e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—atopic dermatitis	1.07e-05	3.28e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MAPK8—atopic dermatitis	1.05e-05	3.22e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCL8—atopic dermatitis	9.13e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL8—atopic dermatitis	8.77e-06	2.68e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2—atopic dermatitis	8.72e-06	2.67e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPARA—atopic dermatitis	8.51e-06	2.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL8—atopic dermatitis	8.51e-06	2.6e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2—atopic dermatitis	8.38e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—atopic dermatitis	8.34e-06	2.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2—atopic dermatitis	8.13e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL8—atopic dermatitis	8.09e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—atopic dermatitis	8.09e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MAPK8—atopic dermatitis	8.03e-06	2.45e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—atopic dermatitis	7.93e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL8—atopic dermatitis	7.74e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2—atopic dermatitis	7.73e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MAPK8—atopic dermatitis	7.71e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—atopic dermatitis	7.7e-06	2.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—atopic dermatitis	7.62e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MAPK8—atopic dermatitis	7.48e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2—atopic dermatitis	7.4e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—atopic dermatitis	7.39e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MAPK8—atopic dermatitis	7.12e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—atopic dermatitis	7.03e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—atopic dermatitis	7.03e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—atopic dermatitis	6.82e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MAPK8—atopic dermatitis	6.81e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPARA—atopic dermatitis	6.8e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—atopic dermatitis	6.73e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—atopic dermatitis	6.49e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—atopic dermatitis	5.13e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—atopic dermatitis	4.93e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—atopic dermatitis	4.78e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—atopic dermatitis	4.55e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—atopic dermatitis	4.35e-06	1.33e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.19e-06	1.28e-05	CbGpPWpGaD
